Abstract:A new method has been developed for the efficient synthesis of Benzisoxazole‐Chromene Acyl Hydrazones (BCA) via C−N coupling followed by condensation under mild reaction conditions. This approach involves sequential aza‐Michael addition and late‐stage functionalization of the formyl group, enabling the synthesis of a diverse range of (E)−N′‐((4‐(4‐(6‐fluorobenzo[d]isoxazol‐3‐yl)piperidin‐1‐yl)‐2H‐chromen‐3‐yl)methylene)benzohydrazide in yields ranging from 58 to 72 %. These newly synthesized BCA analogues were subsequently evaluated in‐silico for their activity against Acetylcholine Esterase (AChE). A new class of benzisoxazole‐Chromene (BC) analogues containing acyl hydrazones BCA (5a‐5m) were obtained by the condensation of different benzo hydrazides with BCs in good yield. All the synthesized BCA analogues were evaluated for their in‐silico activity against Acetylcholine Esterase (AChE). According to docking experiments, the co‐crystallized ligand was outperformed by derivatives 5e (4‐benzisoxazole‐chromene‐3‐(4hydroxyphenyl) acrylohydrazide), 5m (7‐chloro,4‐hydroxy) and 5l (8‐methyl, m‐nitro) showed superior binding modes and binding free energies whereas compound 5j (8‐methyl, 4‐hydroxy) showed appropriate binding energy. These moieties containing acyl hydrazone has shown 4‐fold increase in the binding interactions and orientation. According to ADMET and toxicity studies, derivatives 5e, 5m, 5j, and 5l had the potential to be drugs and have proven to be safe when evaluated using seven toxicity models. Further on checking selectivity with the other cholinesterase enzyme, 5l came out to be selective towards AChE whereas 5e & 5j were acting on another target as well. Finally, DFT analysis validated the binding of the derivatives towards AChE and moreover Molecular Dynamic investigation revealed that 5l is the most capable candidate to interact with the target receptor by comparing its molecular orbital energies, molecular electrostatic potential maps, and ligand movement against the co‐crystallized Ligand.

The New Method for the Preparation of Territrem B Analogues As AChE Inhibitors

Preparation of Analogues of Territrem B, a Potent AChE Inhibitor

Studies on Synthesis of New Territrem B Analogues and Their Biological Activities

Mimetic Preparation of Analogues of Territrem B, A Potent Acetylcholinesterase Inhibitor

Design, Synthesis, and Biological Evaluation of New Territrem B Analogues

Synthesis of 2-En-l-one-ebelactonyl Benzoates of Territrem B Analogues from Jujubogenin

[Synthesis and AchE Inhibitory Activity of 2-Phenoxy-indan-1-one Derivatives].

Synthesis and Biological Evaluation of Pyranone Analogues of Territrem B

Synthesis Of 2-En-1-One-Ebelactonyl Benzoates Of Territrem B Analogues From Jujubogenin

Synthesis of A/B Ring Analogs of Territrem B and Evaluation of Their Biological Activities

Two Series of Synthetic Territrem B Analogues and Their Biological Activities

A New Method for Synthesizing 2-Amino-1-aryl-1- Alcohols and Their Acetylcholinesterase(ache) Inhibition

Effective Asymmetric Preparation of (R)-1-[3-(trifluoromethyl)phenyl]ethanol with Recombinant E. Coli Whole Cells in an Aqueous Tween-20/natural Deep Eutectic Solvent Solution.

Design, Synthesis and Evaluation of Rivastigmine and Curcumin Hybrids As Site-Activated Multitarget-Directed Ligands for Alzheimer's Disease Therapy.

New 3,5-Dimethylorsellinic Acid-Based Meroterpenoids with BACE1 and AchE Inhibitory Activities from Aspergillus Terreus.

Searching for the Multi-Target-Directed Ligands Against Alzheimer’s Disease: Discovery of Quinoxaline-Based Hybrid Compounds with AChE, H3R and BACE 1 Inhibitory Activities

New 2-Aryl-9-methyl-β-carbolinium salts as Potential Acetylcholinesterase Inhibitor agents: Synthesis, Bioactivity and Structure–Activity Relationship

Synthesis of new N‐(5,6‐methylenedioxybenzothiazole‐2‐yl)‐2‐[(substituted)thio/piperazine]acetamide/propanamide derivatives and evaluation of their AChE, BChE, and BACE‐1 inhibitory activities

Preparation of Ache Inhibitors from Jujubogenin

Design, synthesis, in silico, and in vitro evaluation of novel benzyloxybenzene substituted (S)‐α‐amino amide derivatives as cholinesterases and monoaminoxidases inhibitor

Organo Mediated Sustainable Synthesis and In‐Silico Studies of Novel Benzisoxazole‐Chromene Acyl Hydrazones as AChE Inhibitors